Related Experiment Videos
Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?
1Department of Physical Medicine and Rehabilitation, Medical University of South Carolina, Charleston, SC 29425, USA.
The Journal of Head Trauma Rehabilitation
|June 12, 1998
Summary
The Symptom Checklist 90-R Obsessive-Compulsive subscale does not correlate with cognitive function in brain tumor patients. It primarily reflects emotional distress, including depression and anxiety symptoms.
Area of Science:
- Neuropsychology
- Oncology
- Psychiatry
Background:
- Brain tumors significantly impact cognitive function and emotional well-being.
- Assessing psychological distress is crucial for managing patients with brain tumors.
Purpose of the Study:
- To determine the relationship between the Symptom Checklist 90-R Obsessive-Compulsive subscale and cognitive performance in brain tumor patients.
- To explore the construct validity of the Obsessive-Compulsive subscale in this population.
Main Methods:
- Prospective study involving 19 adults with malignant brain tumors.
- Neuropsychological assessment included the Mattis Dementia Rating Scale, California Verbal Learning Test, and Trail Making Test B.
- Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory were administered.
Main Results:
- The Obsessive-Compulsive subscale showed no significant correlation with objective cognitive measures (attention, verbal memory) or age.
- A strong association was found with depression (r = .81) and anxiety (r = .66) symptoms.
- Multivariate analyses revealed depression accounted for 66% of the variance in Obsessive-Compulsive scores, with anxiety contributing an additional 6%.
Conclusions:
- The Symptom Checklist 90-R Obsessive-Compulsive subscale is not a valid measure of cognitive function in brain tumor patients.
- It is best interpreted as an indicator of generalized emotional distress and somatic effects related to brain injury.
- Findings highlight the importance of assessing emotional well-being alongside cognitive function in neuro-oncology.